BioSpace News Archive

Business

Endo Announces Appointment of Laure Park as Senior Vice President, Investor Relations and Corporate Affairs

Laura will serve as a member of Endo’s executive leadership team

August 2, 2018
·
3 min read
Business

Teva Reports Second Quarter 2018 Financial Results

Revenues of $4.7 billion

August 2, 2018
·
39 min read
Bio NC

Aerie Pharmaceuticals to Present at the Canaccord Genuity Growth Conference

Richard Rubino, Chief Financial Officer, will present in a fireside chat discussion at the Canaccord Genuity Growth Conference on Thursday, August 9, 2018 at 1:30 p.m.

August 2, 2018
·
2 min read
Genetown

Frenova Renal Research Adds Fifth Practice to its Site Management Organization (SMO) Business

New Site Expands F1RST Up(r) Alliance, Increasing Volume of Patients Eligible for Clinical Trial Enrollment.

August 2, 2018
·
3 min read
Business

Akcea Therapeutics and PTC Therapeutics Collaborate to Commercialize Two Rare Disease Drugs in Latin America

PTC in-licenses regional rights to TEGSEDI™ and WAYLIVRA™ from Akcea

August 2, 2018
·
10 min read
Business

Nutriband Inc. Announces the Appointment of Larry Dillaha, MD as Chief Medical Officer and to Advisory Board

Dr. Dillaha brings nearly 20 years of pharmaceutical industry experience to Nutriband.

August 2, 2018
·
2 min read
FDA

Certara Software or Services Supported 95% of the US FDA Novel Drug Approvals in First Half of 2018

Modeling and simulation’s positive impact on NDA and BLA approvals through July 1, 2018 has included first use, orphan and priority review drugs for multiple indications

August 2, 2018
·
3 min read
Biotech Beach

PSC Biotech Corporation and PSC Software Announce Acquisition of Three of the Four Largest Pharmaceutical Companies as Customers of Adaptive Compliance Engine™ aka ACE

Three of the four largest pharmaceutical companies in the world use Adaptive Compliance Engine™ aka ACE for enterprise quality management functionality.

August 2, 2018
·
3 min read
Pharm Country

Michael J. Fox Foundation Announces Availability of $7.5 Million in Spring 2019 Funding to Further Research in Parkinson’s Disease Biology, Biomarkers and Therapies

Applications due September 26, 2018

August 2, 2018
·
5 min read
Business

Turkish Pharmaceutical Industry leader, Abdi Ibrahim, selects rfxcel for FMD compliance

Abdi Ibrahim, the Turkish pharmaceutical industry leader, has carefully selected rfxcel to implement and support new compliance management and serialisation processing software to ensure full compliance with current and future international legislative requirements ahead of the 2019 EU Falsified Medicines Directive (FMD) deadline.

August 2, 2018
·
2 min read